drug

Business News

Therma Bright’s AcuVid(TM) U.S. Clinical Performance Study Successfully Exceeds U.S. Food & Drug Administration’s Emergency Use Authorization Requirements – Press Release

Toronto, Ontario–(Newsfile Corp. – February 15, 2022) – Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (“Therma” or the “Company”), developer…

Read More »
Back to top button